Evidence has shown that a decreased peripheral CD8+ T cell count might be a risk factor indicating tumor development and metastasis and could, therefore, be associated with poor prognosis in patients with HCC (41). The gene discussed is CD8A; the disease is hepatocellular carcinoma.